Importantly, we demonstrate that the upregulation of ITGB3 requires accessible chromatin at ITGB3 enhancers to allow for STAT3 binding, but not all cancer cells or tumors are capable of this adaptive response due to inaccessible enhancers. This evidence concerns the gene STAT3 and cancer.